What is Metlife, Inc. share price today?

Metlife, Inc. (MET) share price today is {{live_price}}.

Can Indians buy Metlife, Inc. shares?

Yes, Indians can invest in the Metlife, Inc. (MET) from India. With INDmoney, you can buy Metlife, Inc. at 0 brokerage. The step-by-step process is as follows: Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes) Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates. Once funds are transferred successfully, you can buy Metlife, Inc. at zero transaction cost.

How can I buy Metlife, Inc. shares from India?

It is very easy to buy Metlife, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Metlife, Inc. be purchased?

Yes, you can buy fractional shares of Metlife, Inc. with INDmoney app.

What are the documents required to start investing in Metlife, Inc. stocks?

To start investing in Metlife, Inc., You will need the following documents: Proof of Identification (PAN, Aadhaar etc) Proof of address (Aadhaar, Voter ID etc) These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Metlife, Inc.

Today’s highest price of Metlife, Inc. (MET) is {{1_rba_end}}. Today’s lowest price of Metlife, Inc. (MET) is {{1_rba_st}}.

What is today's market capitalisation of Metlife, Inc.

Today's market capitalisation of Metlife, Inc. MET is 57.7B

What is the 52 Week High and Low Range of Metlife, Inc.

52 Week High {{rba_end}} 52 Week Low {{rba_st}}

How much percentage Metlife, Inc. is down from its 52 Week High?

Metlife, Inc. (MET) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

How much percentage Metlife, Inc. is up from its 52 Week low?

Metlife, Inc. (MET) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

What are the historical returns of Metlife, Inc.?

1 Month Returns {{1mr}}% 3 Months Returns {{3mr}}% 1 Year Returns {{1yr}}% 5 Years Returns {{5yr}}%

Who is the Chief Executive Officer (CEO) of Metlife, Inc.

Mr. Michel Abbas Khalaf is the current Chief Executive Officer (CEO) of Metlife, Inc..

Home>
US Stocks>
Metlife, Inc.

Metlife, Inc. (MET)

$85.19

+2.59

(+3.14%)▲

Market is closed - opens 8 PM, 22 Nov 2024

Performance

$83.29
$85.41
$85.19
2.23%
Downside
Day's Volatility :2.48%
Upside
0.26%
$62.14
$86.95
$85.19
27.06%
Downside
52 Weeks Volatility :28.53%
Upside
2.02%

Returns

Period	Metlife, Inc.	Sector (Financials)	S&P500
3 Months	13.45%	13.1%	5.3%
6 Months	13.79%	17.4%	11.2%
1 Year	32.69%	41.0%	30.4%
3 Years	32.14%	27.0%	26.0%

Highlights

Market Capitalization	57.2B
Book Value	$44.53
Dividend Share	2.13
Dividend Yield	2.64%
Earnings Per Share (EPS)	4.93
PE Ratio	16.76
PEG Ratio	0.14
Wall Street Target Price	90.539

Profit Margin	5.27%
Operating Margin TTM	15.09%

Return On Assets TTM	0.58%
Return On Equity TTM	13.26%

Revenue TTM	71.3B
Revenue Per Share TTM	99.39
Quarterly Revenue Growth YOY	16.2%
Gross Profit TTM	14.9B
EBITDA	7.0B
Diluted Eps TTM	4.93
Quarterly Earnings Growth YOY	2.23

EPS Estimate Current Year	8.34
EPS Estimate Next Year	9.72
EPS Estimate Current Quarter	2.17
EPS Estimate Next Quarter	2.32

Analyst Recommendation

Buy

75%Buy

25%Hold

0%Sell

Based on 20 Wall street analysts offering stock ratings for Metlife, Inc.(by analysts ranked 0 to 5 stars)

Based on 20 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast

What analysts predicted

Upside of 6.28%

Current $85.19

Target $90.54

Company Financials

	FY18	Y/Y Change
Revenue	67.9B	↑ 9.04%
Net Income	5.1B	↑ 27.76%
Net Profit Margin	7.54%	↑ 1.1%

	FY19	Y/Y Change
Revenue	69.6B	↑ 2.47%
Net Income	5.9B	↑ 15.15%
Net Profit Margin	8.47%	↑ 0.93%

	FY20	Y/Y Change
Revenue	67.8B	↓ 2.55%
Net Income	5.4B	↓ 8.34%
Net Profit Margin	7.97%	↓ 0.5%

	FY21	Y/Y Change
Revenue	71.1B	↑ 4.77%
Net Income	6.9B	↑ 26.78%
Net Profit Margin	9.64%	↑ 1.67%

	FY22	Y/Y Change
Revenue	69.9B	↓ 1.66%
Net Income	2.4B	↓ 65.66%
Net Profit Margin	3.37%	↓ 6.27%

	FY23	Y/Y Change
Revenue	66.9B	↓ 4.29%
Net Income	1.6B	↓ 32.97%
Net Profit Margin	2.36%	↓ 1.01%

	Q2 FY23	Q/Q Change
Revenue	16.6B	↑ 8.03%
Net Income	402.0M	↑ 402.5%
Net Profit Margin	2.42%	↑ 1.9%

	Q3 FY23	Q/Q Change
Revenue	15.9B	↓ 4.55%
Net Income	489.0M	↑ 21.64%
Net Profit Margin	3.08%	↑ 0.66%

	Q4 FY23	Q/Q Change
Revenue	19.0B	↑ 19.93%
Net Income	607.0M	↑ 24.13%
Net Profit Margin	3.19%	↑ 0.11%

	Q1 FY24	Q/Q Change
Revenue	16.1B	↓ 15.61%
Net Income	867.0M	↑ 42.83%
Net Profit Margin	5.4%	↑ 2.21%

	Q2 FY24	Q/Q Change
Revenue	17.8B	↑ 11.0%
Net Income	946.0M	↑ 9.11%
Net Profit Margin	5.31%	↓ 0.09%

	Q3 FY24	Q/Q Change
Revenue	18.4B	↑ 3.46%
Net Income	1.3B	↑ 41.86%
Net Profit Margin	7.28%	↑ 1.97%

	FY18	Y/Y Change
Total Assets	687.5B	↓ 4.49%
Total Liabilities	634.6B	↓ 4.0%

	FY19	Y/Y Change
Total Assets	740.5B	↑ 7.7%
Total Liabilities	674.1B	↑ 6.22%

	FY20	Y/Y Change
Total Assets	795.1B	↑ 7.38%
Total Liabilities	720.3B	↑ 6.86%

	FY21	Y/Y Change
Total Assets	759.7B	↓ 4.46%
Total Liabilities	692.0B	↓ 3.94%

	FY22	Y/Y Change
Total Assets	666.6B	↓ 12.25%
Total Liabilities	639.3B	↓ 7.61%

	FY23	Y/Y Change
Total Assets	687.6B	↑ 3.15%
Total Liabilities	657.3B	↑ 2.82%

	Q2 FY23	Q/Q Change
Total Assets	677.3B	↑ 0.45%
Total Liabilities	646.8B	↑ 0.77%

	Q3 FY23	Q/Q Change
Total Assets	652.1B	↓ 3.71%
Total Liabilities	626.2B	↓ 3.18%

	Q4 FY23	Q/Q Change
Total Assets	687.6B	↑ 5.44%
Total Liabilities	657.3B	↑ 4.97%

	Q1 FY24	Q/Q Change
Total Assets	677.6B	↓ 1.46%
Total Liabilities	648.8B	↓ 1.3%

	Q2 FY24	Q/Q Change
Total Assets	675.7B	↓ 0.27%
Total Liabilities	648.2B	↓ 0.09%

	Q3 FY24	Q/Q Change
Total Assets	705.0B	↑ 4.33%
Total Liabilities	673.8B	↑ 3.95%

	FY18	Y/Y Change
Operating Cash Flow	11.7B	↓ 4.44%
Investing Cash Flow	-5.6B	↓ 66.62%
Financing Cash Flow	-2.8B	↑ 209.16%

	FY19	Y/Y Change
Operating Cash Flow	13.8B	↑ 17.45%
Investing Cash Flow	-17.6B	↑ 212.14%
Financing Cash Flow	4.6B	↓ 263.08%

	FY20	Y/Y Change
Operating Cash Flow	11.6B	↓ 15.57%
Investing Cash Flow	-18.6B	↑ 5.59%
Financing Cash Flow	10.7B	↑ 134.87%

	FY21	Y/Y Change
Operating Cash Flow	12.6B	↑ 8.22%
Investing Cash Flow	-11.2B	↓ 39.75%
Financing Cash Flow	-1.4B	↓ 112.82%

	FY22	Y/Y Change
Operating Cash Flow	13.2B	↑ 4.83%
Investing Cash Flow	-2.6B	↓ 76.58%
Financing Cash Flow	-10.1B	↑ 635.13%

	Q2 FY23	Q/Q Change
Operating Cash Flow	3.0B	↑ 49.95%
Investing Cash Flow	-6.3B	↑ 321.94%
Financing Cash Flow	379.0M	↓ 116.51%

	Q3 FY23	Q/Q Change
Operating Cash Flow	3.5B	↑ 14.38%
Investing Cash Flow	-10.8B	↑ 70.53%
Financing Cash Flow	-848.0M	↓ 323.75%

Technicals Summary

Sell

Neutral

Buy

Metlife, Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Metlife, Inc.	-2.64%	13.79%	32.69%	32.14%	68.67%
Manulife Financial Corporation	7.09%	21.99%	68.61%	67.12%	65.74%
Aflac Inc.	-2.23%	25.86%	34.6%	97.35%	104.64%
Prudential Plc	-6.26%	-21.73%	-30.64%	-58.05%	-51.56%
Prudential Financial, Inc.	-1.16%	5.32%	31.72%	15.47%	32.65%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Metlife, Inc.	16.9	16.76	0.14	8.34	0.13	0.01	0.03	44.53
Manulife Financial Corporation	16.25	16.2	1.01	3.77	0.12	0.01	0.04	27.05
Aflac Inc.	16.51	16.51	0.93	7.15	0.16	0.02	0.02	44.6
Prudential Plc	25.2	24.75	0.36	1.72	0.05	0.01	0.03	5.9
Prudential Financial, Inc.	11.1	11.1	0.53	13.38	0.14	0.0	0.04	85.46

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Metlife, Inc.	Buy	$57.7B	68.67%	16.9	5.27%
Manulife Financial Corporation	Buy	$57.4B	65.74%	16.25	18.98%
Aflac Inc.	Hold	$61.7B	104.64%	16.51	22.02%
Prudential Plc	Buy	$21.5B	-51.56%	25.2	8.01%
Prudential Financial, Inc.	Hold	$44.4B	32.65%	11.1	5.62%

Insights on Metlife, Inc.

Increasing Revenue
Revenue is up for the last 3 quarters, 16.05B → 18.44B (in $), with an average increase of 6.6% per quarter
Increasing Net Profit
Netprofit is up for the last 7 quarters, 80.0M → 1.34B (in $), with an average increase of 30.9% per quarter
Vs MFC
In the last 1 year, Manulife Financial Corporation has given 68.6% return, outperforming this stock by 35.9%
Vs AFL
In the last 3 years, Aflac Inc. has given 66.6% return, outperforming this stock by 31.5%

Institutional Holdings

Vanguard Group Inc
8.42%
Dodge & Cox
7.89%
BlackRock Inc
6.86%
T. Rowe Price Associates, Inc.
4.65%
State Street Corp
3.86%
Morgan Stanley - Brokerage Accounts
3.39%

Corporate Announcements

Metlife, Inc. Dividends March,2024
In the quarter ending March,2024. Metlife, Inc. has declared dividend of $0.52
Read More

Organization	Metlife, Inc.
Employees	45000
CEO	Mr. Michel Abbas Khalaf
Industry	Finance

Metlife, Inc. (MET)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Company Financials

Technicals Summary

Peers

Increasing Revenue

Increasing Net Profit

Vs MFC

Vs AFL

Institutional Holdings

Corporate Announcements

Metlife, Inc. Dividends March,2024

Company Information

Discover More

FAQs